Global law firm White & Case LLP has advised Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, on its participation in a US$160 million Series C financing of Century Therapeutics, a leading cell therapy company headquartered in Philadelphia developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology.
The financing closed on 3 March 2021.
The White & Case team which advised on the transaction was led by partner Gary Silverman (Chicago) and included partners Charles Larsen, Anita Varma (both Boston), Michiel Visser (New York) and Andrew Kreisberg (Los Angeles), and associates David Smith (Frankfurt), Matthew Sieben (Chicago), Michelle Ife Irukera, Robin Heszkel and Ilan Har-El (all New York).
Press contact
For more information please speak to your local media contact.
